Free Trial
NASDAQ:CGC

Canopy Growth (CGC) Stock Price, News & Analysis

Canopy Growth logo
$1.01 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.01 +0.00 (+0.50%)
As of 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Canopy Growth Stock (NASDAQ:CGC)

Advanced

Key Stats

Today's Range
$0.97
$1.02
50-Day Range
$0.95
$1.38
52-Week Range
$0.84
$2.38
Volume
8.64 million shs
Average Volume
10.85 million shs
Market Capitalization
$408.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Canopy Growth Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

CGC MarketRank™: 

Canopy Growth scored higher than 38% of companies evaluated by MarketBeat, and ranked 709th out of 863 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Canopy Growth has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on no strong buy ratings, 2 buy ratings, 3 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Canopy Growth has only been the subject of 3 research reports in the past 90 days.

  • Read more about Canopy Growth's stock forecast and price target.
  • Earnings Growth

    Earnings for Canopy Growth are expected to grow in the coming year, from ($0.36) to ($0.11) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Canopy Growth is -0.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Canopy Growth is -0.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Canopy Growth has a P/B Ratio of 0.53. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Canopy Growth's valuation and earnings.
  • Percentage of Shares Shorted

    5.61% of the float of Canopy Growth has been sold short.
  • Short Interest Ratio / Days to Cover

    Canopy Growth has a short interest ratio ("days to cover") of 2.76, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Canopy Growth has recently decreased by 1.75%, indicating that investor sentiment is improving.
  • Dividend Yield

    Canopy Growth does not currently pay a dividend.

  • Dividend Growth

    Canopy Growth does not have a long track record of dividend growth.

  • News Sentiment

    Canopy Growth has a news sentiment score of 1.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Canopy Growth this week, compared to 5 articles on an average week.
  • Search Interest

    Only 21 people have searched for CGC on MarketBeat in the last 30 days. This is a decrease of -19% compared to the previous 30 days.
  • MarketBeat Follows

    12 people have added Canopy Growth to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Canopy Growth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $14,048.00 in company stock.

  • Percentage Held by Insiders

    0.16% of the stock of Canopy Growth is held by insiders.

  • Percentage Held by Institutions

    3.33% of the stock of Canopy Growth is held by institutions.

  • Read more about Canopy Growth's insider trading history.
Receive CGC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Canopy Growth and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CGC Stock News Headlines

Canopy Growth (NASDAQ:CGC) & Nephros (NASDAQ:NEPH) Financial Review
$30 stock to buy before Starlink goes public (WATCH NOW!)
A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker.tc pixel
Canopy Growth (CGC) to Release Earnings on Monday
See More Headlines

CGC Stock Analysis - Frequently Asked Questions

Canopy Growth's stock was trading at $1.14 on January 1st, 2026. Since then, CGC stock has decreased by 11.4% and is now trading at $1.01.

Canopy Growth Corporation (NASDAQ:CGC) posted its earnings results on Friday, February, 6th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.03) by $0.07. The company had revenue of $90.39 million for the quarter, compared to the consensus estimate of $70.96 million. Canopy Growth had a negative net margin of 94.39% and a negative trailing twelve-month return on equity of 46.85%.
Read the conference call transcript
.

Canopy Growth shares reverse split on the morning of Wednesday, December 20th 2023.The 1-10 reverse split was announced on Wednesday, December 13th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, December 19th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Top institutional shareholders of Canopy Growth include Lazard Asset Management LLC (0.45%), Royal Bank of Canada (0.24%), Baader Bank Aktiengesellschaft (0.09%) and AdvisorShares Investments LLC (0.07%). Insiders that own company stock include Luc Mongeau, Christelle Gedeon, Judy Eun Joo Hong, Thomas Carlton Stewart, Willy Kruh, Theresa Yanofsky, M Shan Atkins, Joseph Bayern and David Angelo Lazzarato.
View institutional ownership trends
.

Shares of CGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Canopy Growth investors own include NVIDIA (NVDA), Meta Platforms (META), Alibaba Group (BABA), Micron Technology (MU), GE Aerospace (GE), BMO Capital Markets () and Stifel Nicolaus ().

Company Calendar

Last Earnings
2/06/2026
Today
6/11/2026
Next Earnings (Confirmed)
6/15/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CGC
CIK
1737927
Fax
N/A
Employees
3,150
Year Founded
2014

Profitability

EPS (Trailing Twelve Months)
($1.30)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$429.86 million
Net Margins
-94.39%
Pretax Margin
-95.11%
Return on Equity
-46.85%
Return on Assets
-28.95%

Debt

Debt-to-Equity Ratio
0.30
Current Ratio
5.34
Quick Ratio
4.26

Sales & Book Value

Annual Sales
$278.39 million
Price / Sales
1.47
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.90 per share
Price / Book
0.53

Miscellaneous

Outstanding Shares
404,124,000
Free Float
403,477,000
Market Cap
$408.17 million
Optionable
Optionable
Beta
0.77

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:CGC) was last updated on 6/11/2026 by MarketBeat.com Staff.
From Our Partners